Clinical research - Press Releases

Date	Title	Company
12-Oct-2023	Pioneering AI solutions and a commitment to industry-wide RBQM advancement secures CluePoints a finalist position in the 2023 SCRIP Awards	CluePoints
12-Oct-2023	CD Bioparticles Launches 3D Cell Culture Substrate for Bio-research	CD Bioparticles
12-Oct-2023	STEMart Announces Rapid Endotoxin Testing Services for Medical Devices	STEMart
10-Oct-2023	Valo Therapeutics Announces Acquisition of Bruker Corporation’s Latest Mass Spectrometer Platform for Tumor Antigen Identification with ValoTx’s PeptiCHIP Technology	Valo Therapeutics
10-Oct-2023	GPCR Therapeutics Expands Pipeline into Fibrosis with a Combination Approach Targeting LPA1	GPCR Therapeutics
10-Oct-2023	New guidance launches to enhance quality and improve patient experience in healthcare sector	BSI
10-Oct-2023	Innovative Trials launches ‘first of its kind’ service to boost clinical trial patient recruitment and retention	Innovative Trials
10-Oct-2023	Life sciences leaders unite to condemn radical plans to rewrite medicines scheme	British Pharmaceutical Industry (ABPI)
10-Oct-2023	Brandon Capital Joins AstronauTx’ £48 million ($61 million) Series A Financing to Create New Treatments for Alzheimer’s disease	Brandon Capital
10-Oct-2023	Pheon Therapeutics Appoints Oncology Expert Arvin Yang, MD, PhD as Chief Medical Officer	Pheon Therapeutics
10-Oct-2023	Novotech Secures Consecutive Frost & Sullivan CRO Company of the Year Award	Novotech
10-Oct-2023	LYNPARZA (OLAPARIB) ACCEPTED FOR USE IN SCOTLAND AS ADJUVANT TREATMENT FOR PATIENTS WITH GERMLINE BRCA-MUTATED HER2-NEGATIVE HIGH RISK EARLY BREAST CANCER	AstraZeneca
10-Oct-2023	Elsevier launches new PharmaPendium, empowering pharma companies to bring novel drugs to market faster and increase success of regulatory submissions	Elsevier
10-Oct-2023	Cryoport and Cell and Gene Therapy Catapult Announce Strategic Collaboration at Stevenage Manufacturing Innovation Centre for Advancement of Cell and Gene Therapies	Cryoport, Inc
10-Oct-2023	Creative Diagnostics Launches New Azaperone Test Reagents for Research Applications	Creative Diagnostics
10-Oct-2023	Creative Diagnostics Launches Checkerboard Assay Services	Creative Diagnostics
10-Oct-2023	Creative Diagnostics Launches New Anti-Small Molecule Label Antibodies to Facilitate NALFIA Development	Creative Diagnostics
05-Oct-2023	Veranova Announces Appointment of New Advisory Board	Veranova
05-Oct-2023	UK Launches Its First National Total-Body PET Platform for Drug Discovery	Medicines Discovery Catapult
04-Oct-2023	Phastar Net-Zero Target Approved by the Science Based Targets Initiative	Phastar